Paper Details

  1. Home
  2. Paper Details

Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis.

Author: CarrWarner, ChippsBradley E, EdwardsMichael, LaForceCraig F, MeltzerEli O, StormsWilliam, TillesStephen A

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study evaluated the safety and efficacy of olopatadine hydrochloride nasal spray, 0.6% (OLO), administered in combination with fluticasone nasal spray, 50 micrograms (FNS), relative to azelastine nasal spray, 0.1% (AZE), administered in combination with FNS in the treatment of SAR. OLO, when administered adjunctively with FNS, is effective, safe, and well-tolerated in patients with SAR.
Paper Details　
Original Abstract of the Article :
The combination of intranasal antihistamines and intranasal corticosteroids results in superior relief of seasonal allergic rhinitis (SAR) symptoms compared with monotherapy. This study was designed to evaluate the safety and efficacy of olopatadine hydrochloride nasal spray, 0.6% (OLO), administere...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.2500/aap.2010.31.3326

データ提供：米国国立医学図書館（NLM）

Olopatadine Hydrochloride Nasal Spray: A Potential Solution for Seasonal Allergies?

The [battle against seasonal allergies] is a common one, with many people seeking relief from those dreaded [sniffles and sneezes]. This research delves into the effectiveness of [olopatadine hydrochloride nasal spray] in combination with [fluticasone nasal spray], a common treatment for [seasonal allergic rhinitis (SAR)]. The study aims to determine if this combination is a [winning formula] for battling allergy symptoms, comparing it to another popular combination treatment.

A Promising Combination for Allergy Relief

The research reveals that the combination of olopatadine hydrochloride and fluticasone nasal spray is [effective and well-tolerated] in patients with SAR. This suggests that this treatment could offer [relief for allergy sufferers] without causing significant side effects. This finding is particularly exciting as it potentially provides a safe and effective alternative for [those seeking relief from allergy symptoms].

Navigating Allergy Season with Confidence

Understanding how different medications work is crucial for [managing allergies]. This research provides valuable information for patients and healthcare providers, highlighting a potential [powerful weapon in the fight against allergies]. By understanding the effectiveness of olopatadine hydrochloride in combination with fluticasone, individuals can make informed decisions about their allergy treatment.

Dr.Camel's Conclusion

This study is like a [cool breeze] on a scorching desert day, offering relief for allergy sufferers. The finding that this combination treatment is effective and well-tolerated is truly [encouraging], and I believe it could play a significant role in improving the lives of many people who struggle with allergies.

Date :
  1. Date Completed 2010-09-14
  2. Date Revised 2016-10-20
Further Info :

Pubmed ID

20302683

DOI: Digital Object Identifier

10.2500/aap.2010.31.3326

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.